Production / Operations
Cascades strengthens its tissue paper production platform in Quebec
Cascades doubles down on Quebec tissue capacity with $15M capex; execution remains the key to margin recovery.
Executive Summary
- Cascades Inc. is investing $15 million to install a new state-of-the-art tissue converting line at its Granby, Quebec facility.
- Total recent site investment reaches $29 million.
- New line capacity is 3 million cases, scheduled to begin operations in Q4 2026.
- Project targets sustained retail demand for regular and multi-pack toilet paper.
- Investment secures 239 existing jobs at the plant.
- Strategic rationale focuses on enhancing production capacity, improving product quality, and aligning with long-term growth strategy.
Material Impact
- The $15 million tissue line investment is a routine capital allocation decision fully consistent with the $150M–$175M 2026 capex budget. It contains no genuinely new market-relevant information, no guide-raise, and no strategic pivot.
- The stock's +3.5% move into the print confirms that expectations were low and the market had already discounted the operational headwinds. The news is not material and will not re-rate the business.
CAS · Price
Company Overview
- Cascades Inc. is a North American packaging, hygiene, and recovery solutions provider.
- Operates through Packaging Products, Tissue Papers, and Corporate/Recovery segments.
- Strategic focus centers on optimizing the operational platform, reducing debt, and investing in core markets like Quebec tissue and uncoated recycled boxboard.
- Emphasizes sustainability commitments, including SBTi-aligned GHG reduction and deforestation-free fibre sourcing.
More from CASCADES INC.
Jun 17, 2026 · 11:00